Bruno Montico Costa

Bruno Montico Costa

Auto-generated profile, based on publicly available information

Bruno Montico Costa

Universidade de São Paulo, Faculdade de Medicina, Departamento de Infectologia, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2026 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
GFGabriel Fialkovitz
Gabriel Fialkovitz
PSPedro Lobo Sousa
Pedro Lobo Sousa
AHAmanda Miyuki Hidifira
Amanda Miyuki Hidifira
GBGustavo Henrique Pereira Boog
Gustavo Henrique Pereira Boog
BCBruno Montico Costa
Bruno Montico Costa
ALAnna Sara Levin
Anna Sara Levin
The COVID-19 pandemic highlighted the urgent need for rapid and accurate SARS-CoV-2 detection. Current diagnostic methods often suffer from discomfort, slow results, and limited accuracy in early infection stages. This study proposes a solution: a noninvasive, rapid, and accurate detection approach for point-of-care settings using a metal-oxide-sensor-based electronic nose. This innovative electronic nose uses an array of off-the-shelf gas sensors. These sensors detect and analyze the volatile organic compounds present in saliva and exhaled breath, which change based on the presence of the SARS-CoV-2 virus. We evaluated the discriminatory power of the electronic nose using a suite of machine learning algorithms, specifically K-Nearest Neighbors (KNN), Support Vector Machine (SVM), Neural Networks (NN), and Random Forest, to differentiate between SARS-CoV-2 infected and non-infected samples. Accuracy metrics ranged from 76% to 89% for exhaled breath samples and from 75% to 86% for saliva samples. Optimal accuracy was achieved with the KNN algorithm, yielding an Area Under the Curve (AUC) of 0.861 (95% CI 0.825‒0.897) for saliva and 0.895 (95% CI 0.850‒0.940) for exhaled breath. These results support the feasibility and proof-of-concept performance of a low-cost electronic nose for SARS-CoV-2 detection in a real-world hospital cohort.